Not available
Quote | Hisamitsu Pharm Co Ltd (OTCMKTS:HTSUF)
Last: | $25.22 |
---|---|
Change Percent: | 0.0% |
Open: | $25.22 |
Close: | $25.22 |
High: | $25.22 |
Low: | $25.22 |
Volume: | 198 |
Last Trade Date Time: | 04/11/2024 03:00:00 am |
News | Hisamitsu Pharm Co Ltd (OTCMKTS:HTSUF)
Hisamitsu Pharmaceutical ([[HTSUF]]) company Noven Pharmaceuticals has submitted a New Drug Application to the U.S. FDA seeking approval to market its dextroamphetamine transdermal system ((ATS)) for the treatment of Attention Deficit Hyperactivity Disorder ((ADHD)).Noven’s ATS is...
Hisamitsu Pharmaceutical Co. ( OTCPK:HTSUF ) subsidiary Noven Pharmaceuticals announces the FDA nod for SECUADO (asenapine) transdermal patch for the treatment of adults with schizophrenia. More news on: Hisamitsu Pharmaceutical Co., Inc., Allergan plc, Merck & Co., Inc., Healthcare ...
Message Board Posts | Hisamitsu Pharm Co Ltd (OTCMKTS:HTSUF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |